The Ethical Concerns of Improper Semaglutide Administration After Acquisition From A Compounded Pharmacy

Authors

Syed Basit Haider, HCA HealthcareFollow
Renu Thomas, HCA HealthcareFollow
E’Joven Reed, HCA HealthcareFollow
Aneesha Shaju, HCA HealthcareFollow
Bushra Bangash, HCA HealthcareFollow
Jakob Schnell, HCA HealthcareFollow
Edrianna Mae Ablola, HCA HealthcareFollow

Files

Division

Gulf Coast

Hospital

HCA Houston Healthcare Kingwood

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2024

Keywords

semaglutide, ethics, off-label use, obesity

Disciplines

Internal Medicine | Medicine and Health Sciences | Therapeutics

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Haider, Syed Basit; Thomas, Renu; Reed, E’Joven; Shaju, Aneesha; Bangash, Bushra; Schnell, Jakob; and Ablola, Edrianna Mae, "The Ethical Concerns of Improper Semaglutide Administration After Acquisition From A Compounded Pharmacy" (2024). Gulf Coast Division Research Symposium 2024. 42.
https://scholarlycommons.hcahealthcare.com/gulfcoast2024/42